Ventuno Biotech: Funding, Investors & Team (Sep 2026)
Ventuno Biotech is a biotech company that is developing innovative cancer therapies.
Ventuno Biotech has raised $2.3M across 1 funding round on record, the most recent a Seed of $2.3M announced in Nov 2025.
That round is below the $15M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ventuno Biotech Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Ventuno Biotech Funding Rounds
Ventuno Biotech Founders and Leadership Team
Contact details for the Ventuno Biotech team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Ventuno Biotech Funding Compared to Other Biotechnology Startups
Ventuno Biotech's latest round of $2.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ventuno Biotech in Biotechnology and Lyon
Companies Similar to Ventuno Biotech
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific…
Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading…
Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures…
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the…
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and…
Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe…
Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for…
Treating the seeds of cancer
Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.
Ventuno Biotech Funding FAQs
What does Ventuno Biotech do?
Ventuno Biotech is a biotech company that is developing innovative cancer therapies.
How much funding has Ventuno Biotech raised?
Ventuno Biotech has raised $2.3M across 1 round on record. The most recent is a Seed of $2.3M announced in Nov 2025.
When did Ventuno Biotech last raise funding?
Ventuno Biotech's most recent funding round on record is a Seed of $2.3M, announced in Nov 2025.
Where is Ventuno Biotech headquartered?
Ventuno Biotech is based in Lyon, France.
How many employees does Ventuno Biotech have?
Ventuno Biotech is in the 1-10 employee band.
How does Ventuno Biotech's funding compare to other Biotechnology startups?
Ventuno Biotech's latest round of $2.3M is below the $15M median round size for Biotechnology companies on FundedIQ across 16 tracked companies over the last two years.
About FundedIQ's Ventuno Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ventuno Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.